When we glanced in the mirror this morning we did a double take. Our eyes were looking far more glam than we’re accustomed to in the a.m. Had we forgotten to take off our eye makeup?
We rubbed our eyes. No black smudges. And then we remembered: A few weeks ago we had begun brushing the eyelash enhancer RevitaLash along our upper and lower lash line each night. We’d been inspired by a beauty-savvy friend who had given up her monthly $200 eyelash-extension appointments once she discovered her naturally stubby lashes grew to rain-forest lushness with a few swipes of the lash conditioner.
Now we understand her decision: After less than a month our own weepers are already sporting a decidedly more dramatic fringe.
In the winter of 2007, as you may have heard, there was a bit of an FDA dust-up when Allergan filed suit against several manufacturers of lash conditioners that contained the ingredient bimatoprost, which the pharmaceutical company sells in its anti-glaucoma eye drops. The over-the-counter lash products tweaked their formulas, and Allergan is now marketing Latisse, a brush-on version of its glaucoma drug, as a prescription remedy for “hypotrichosis” or “inadequate” lashes. Latisse will cost $120 for a one-month supply. (A $150 tube of RevitaLash lasts five to six months.)
All this intrigue means more options for the beauty consumer. But be aware that both Latisse and Revitalash have one limitation: Stop using them and your beefed-up lashes will return to their pre-treatment state.